Last 12 months
Inside the activity.
1 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2025 Filed Aug 19, 2025 21:15 UTC |
Jones Nicole SSee Remarks
|
SaleCommon Stock, $.01 Par Value | 28,526 | $300.00 | $8,557,800.00 |
DisclosureSEC source: 0001225208-25-007353 · doc4.xml · nonDerivative · entry 3 Jones Nicole S · CIK 0001492663 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,648 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2025. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 21:15 UTC |
Jones Nicole SSee Remarks
|
Exercise / conversionCommon Stock, $.01 Par Value | 11,598 | $183.44 | $2,127,542.92 |
DisclosureSEC source: 0001225208-25-007353 · doc4.xml · nonDerivative · entry 2 Jones Nicole S · CIK 0001492663 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2025. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 21:15 UTC |
Jones Nicole SSee Remarks
|
Exercise / conversionCommon Stock, $.01 Par Value | 13,155 | $197.35 | $2,596,139.25 |
DisclosureSEC source: 0001225208-25-007353 · doc4.xml · nonDerivative · entry 1 Jones Nicole S · CIK 0001492663 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2025. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:58 UTC |
Hennigan Michael JDirector
|
GrantCommon Stock, $.01 Par Value | 568 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-005715 · doc4.xml · nonDerivative · entry 1 Hennigan Michael J · CIK 0001352283 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 568 Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:04 UTC |
Kurian GeorgeDirector
|
GrantPhantom Stock Units · Derivative | 94.7448 | $316.64 | $29,999.99 |
DisclosureSEC source: 0001225208-25-005682 · doc4.xml · derivative · entry 1 Kurian George · CIK 0001586813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,467.7887 Underlying: Common Stock, $.01 Par Value · 94.7448 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F2 · balance_after: Includes 6.4209 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:32 UTC |
Ozuah PhilipDirector
|
GrantCommon Stock, $.01 Par Value | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004426 · doc4.xml · nonDerivative · entry 1 Ozuah Philip · CIK 0001859685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,801 Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:32 UTC |
Hathi NeeshaDirector
|
GrantCommon Stock, $.01 Par Value | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004423 · doc4.xml · nonDerivative · entry 1 Hathi Neesha · CIK 0001879974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,369 Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:33 UTC |
ZARCONE DONNA FDirector
|
GrantCommon Stock, $.01 Par Value | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004430 · doc4.xml · nonDerivative · entry 1 ZARCONE DONNA F · CIK 0001243083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,735 F1 · balance_after: The reporting person's economic interest in The Cigna Group securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of The Cigna Group stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than The Cigna Group stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for The Cigna Group and pages 48-49 and 111 of The Cigna Group's proxy statement filed with the SEC on March 14, 2025. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:33 UTC |
WISEMAN ERIC CDirector
|
GrantCommon Stock, $.01 Par Value | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004429 · doc4.xml · nonDerivative · entry 1 WISEMAN ERIC C · CIK 0001237851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,158 F1 · balance_after: The reporting person's economic interest in The Cigna Group securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of The Cigna Group stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than The Cigna Group stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for The Cigna Group and pages 48-49 and 111 of The Cigna Group's proxy statement filed with the SEC on March 14, 2025. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:33 UTC |
Kurian GeorgeDirector
|
GrantCommon Stock, $.01 Par Value | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004428 · doc4.xml · nonDerivative · entry 1 Kurian George · CIK 0001586813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,778 F1 · balance_after: The reporting person's economic interest in The Cigna Group securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of The Cigna Group stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than The Cigna Group stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for The Cigna Group and pages 48-49 and 111 of The Cigna Group's proxy statement filed with the SEC on March 14, 2025. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:32 UTC |
MAZZARELLA KATHLEEN MDirector
|
GrantCommon Stock, $.01 Par Value | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004424 · doc4.xml · nonDerivative · entry 1 MAZZARELLA KATHLEEN M · CIK 0001273233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,109 Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:33 UTC |
Ross Kimberly A.Director
|
GrantCommon Stock, $.01 Par Value | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004427 · doc4.xml · nonDerivative · entry 1 Ross Kimberly A. · CIK 0001536350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,512 Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:32 UTC |
McClellan Mark B.Director
|
GrantCommon Stock, $.01 Par Value | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004425 · doc4.xml · nonDerivative · entry 1 McClellan Mark B. · CIK 0001567006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,109 Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:32 UTC |
Granger ElderDirector
|
GrantCommon Stock, $.01 Par Value | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004422 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,109 Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:32 UTC |
FOSS ERIC JDirector
|
GrantCommon Stock, $.01 Par Value | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004421 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,914 Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 21:06 UTC |
Granger ElderDirector
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,376 | $0.00 Strike: $151.48 | $0.00 |
DisclosureSEC source: 0001225208-25-003437 · doc4.xml · derivative · entry 3 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 2,376 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2024. F2 · derivative.exercise_date: These stock options were granted on May 4, 2016 and were fully vested at the closing of the acquisition of Express Scripts Holding Company on December 20, 2018. Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 21:06 UTC |
Granger ElderDirector
|
SaleCommon Stock, $.01 Par Value | 2,376 | $310.35 | $737,391.60 |
DisclosureSEC source: 0001225208-25-003437 · doc4.xml · nonDerivative · entry 2 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,471 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2024. Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 21:06 UTC |
Granger ElderDirector
|
Exercise / conversionCommon Stock, $.01 Par Value | 2,376 | $151.48 | $359,913.15 |
DisclosureSEC source: 0001225208-25-003437 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2024. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 21:11 UTC |
Eder Noelle KSee Remarks
|
SaleCommon Stock, $.01 Par Value | 9,944 | $320.00 | $3,182,080.00 |
DisclosureSEC source: 0001225208-25-003245 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,406 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 00:52 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 26,527 | $308.12 | $8,173,499.24 |
DisclosureSEC source: 0001225208-25-002922 · doc4.xml · nonDerivative · entry 5 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 127,767 F6 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2024. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 00:52 UTC |
Jones Nicole SSee Remarks
|
SaleCommon Stock, $.01 Par Value | 4,904 | $308.12 | $1,511,020.48 |
DisclosureSEC source: 0001225208-25-002921 · doc4.xml · nonDerivative · entry 5 Jones Nicole S · CIK 0001492663 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,421 F5 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2024. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Kates Jamie GChief Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 871 | $0.00 Strike: $305.86 | $0.00 |
DisclosureSEC source: 0001225208-25-002928 · doc4.xml · derivative · entry 5 Kates Jamie G · CIK 0002029677 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 871 Underlying: Common Stock, $.01 Par Value · 871 shares Expires 2035-02-28 F5 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2026. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Kates Jamie GChief Accounting Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 130 | $305.86 | $39,761.80 |
DisclosureSEC source: 0001225208-25-002928 · doc4.xml · nonDerivative · entry 4 Kates Jamie G · CIK 0002029677 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,686 F4 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Kates Jamie GChief Accounting Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 51 | $305.86 | $15,598.86 |
DisclosureSEC source: 0001225208-25-002928 · doc4.xml · nonDerivative · entry 3 Kates Jamie G · CIK 0002029677 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,816 F3 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Kates Jamie GChief Accounting Officer
|
GrantCommon Stock, $.01 Par Value | 246 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002928 · doc4.xml · nonDerivative · entry 2 Kates Jamie G · CIK 0002029677 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,867 F2 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2026. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Kates Jamie GChief Accounting Officer
|
GrantCommon Stock, $.01 Par Value | 405 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002928 · doc4.xml · nonDerivative · entry 1 Kates Jamie G · CIK 0002029677 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,621 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
BRAILER DAVID JEVP & Chief Health Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 23,222 | $0.00 Strike: $305.86 | $0.00 |
DisclosureSEC source: 0001225208-25-002927 · doc4.xml · derivative · entry 5 BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,222 Underlying: Common Stock, $.01 Par Value · 23,222 shares Expires 2035-02-28 F5 · derivative.exercise_date: This option vests in full on March 1, 2026. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
BRAILER DAVID JEVP & Chief Health Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 2,632 | $305.86 | $805,023.52 |
DisclosureSEC source: 0001225208-25-002927 · doc4.xml · nonDerivative · entry 4 BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,815 F4 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
BRAILER DAVID JEVP & Chief Health Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 775 | $305.86 | $237,041.50 |
DisclosureSEC source: 0001225208-25-002927 · doc4.xml · nonDerivative · entry 3 BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,447 F3 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
BRAILER DAVID JEVP & Chief Health Officer
|
GrantCommon Stock, $.01 Par Value | 5,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002927 · doc4.xml · nonDerivative · entry 2 BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,222 F2 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
BRAILER DAVID JEVP & Chief Health Officer
|
GrantCommon Stock, $.01 Par Value | 6,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002927 · doc4.xml · nonDerivative · entry 1 BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,582 F1 · shares: These restricted shares vest in full on March 1, 2026. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Palmer Eric PSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 19,158 | $0.00 Strike: $305.86 | $0.00 |
DisclosureSEC source: 0001225208-25-002926 · doc4.xml · derivative · entry 8 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,158 Underlying: Common Stock, $.01 Par Value · 19,158 shares Expires 2035-02-28 F6 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2026. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Palmer Eric PSee Remarks
|
Tax withholdingCommon Stock, $.01 Par Value | 7,407 | $305.86 | $2,265,505.02 |
DisclosureSEC source: 0001225208-25-002926 · doc4.xml · nonDerivative · entry 4 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,160 F4 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Palmer Eric PSee Remarks
|
Tax withholdingCommon Stock, $.01 Par Value | 2,083 | $305.86 | $637,106.38 |
DisclosureSEC source: 0001225208-25-002926 · doc4.xml · nonDerivative · entry 3 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,567 F3 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Palmer Eric PSee Remarks
|
GrantCommon Stock, $.01 Par Value | 5,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002926 · doc4.xml · nonDerivative · entry 2 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,650 F2 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2026. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Palmer Eric PSee Remarks
|
GrantCommon Stock, $.01 Par Value | 15,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002926 · doc4.xml · nonDerivative · entry 1 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,255 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Evanko Brian CSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 19,158 | $0.00 Strike: $305.86 | $0.00 |
DisclosureSEC source: 0001225208-25-002924 · doc4.xml · derivative · entry 6 Evanko Brian C · CIK 0001722909 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,158 Underlying: Common Stock, $.01 Par Value · 19,158 shares Expires 2035-02-28 F6 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2026. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Evanko Brian CSee Remarks
|
Tax withholdingCommon Stock, $.01 Par Value | 5,679 | $305.86 | $1,736,978.94 |
DisclosureSEC source: 0001225208-25-002924 · doc4.xml · nonDerivative · entry 4 Evanko Brian C · CIK 0001722909 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,182 F4 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Evanko Brian CSee Remarks
|
Tax withholdingCommon Stock, $.01 Par Value | 1,722 | $305.86 | $526,690.92 |
DisclosureSEC source: 0001225208-25-002924 · doc4.xml · nonDerivative · entry 3 Evanko Brian C · CIK 0001722909 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,861 F3 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Evanko Brian CSee Remarks
|
GrantCommon Stock, $.01 Par Value | 5,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002924 · doc4.xml · nonDerivative · entry 2 Evanko Brian C · CIK 0001722909 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,583 F2 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2026. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Evanko Brian CSee Remarks
|
GrantCommon Stock, $.01 Par Value | 12,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002924 · doc4.xml · nonDerivative · entry 1 Evanko Brian C · CIK 0001722909 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,188 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Eder Noelle KSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 11,176 | $0.00 Strike: $305.86 | $0.00 |
DisclosureSEC source: 0001225208-25-002925 · doc4.xml · derivative · entry 6 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,176 Underlying: Common Stock, $.01 Par Value · 11,176 shares Expires 2035-02-28 F6 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2026. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Eder Noelle KSee Remarks
|
Tax withholdingCommon Stock, $.01 Par Value | 3,709 | $305.86 | $1,134,434.74 |
DisclosureSEC source: 0001225208-25-002925 · doc4.xml · nonDerivative · entry 4 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,350 F4 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Eder Noelle KSee Remarks
|
Tax withholdingCommon Stock, $.01 Par Value | 914 | $305.86 | $279,556.04 |
DisclosureSEC source: 0001225208-25-002925 · doc4.xml · nonDerivative · entry 3 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,059 F3 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Eder Noelle KSee Remarks
|
GrantCommon Stock, $.01 Par Value | 3,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002925 · doc4.xml · nonDerivative · entry 2 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,973 F2 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2026. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Eder Noelle KSee Remarks
|
GrantCommon Stock, $.01 Par Value | 8,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002925 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,826 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Cordani DavidDirector · Chairman & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 39,476 | $0.00 Strike: $305.86 | $0.00 |
DisclosureSEC source: 0001225208-25-002922 · doc4.xml · derivative · entry 9 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,476 Underlying: Common Stock, $.01 Par Value · 39,476 shares Expires 2035-02-28 F8 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2026. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Cordani DavidDirector · Chairman & CEO
|
Tax withholdingCommon Stock, $.01 Par Value | 22,910 | $305.86 | $7,007,252.60 |
DisclosureSEC source: 0001225208-25-002922 · doc4.xml · nonDerivative · entry 4 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,294 F5 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Cordani DavidDirector · Chairman & CEO
|
Tax withholdingCommon Stock, $.01 Par Value | 4,696 | $305.86 | $1,436,318.56 |
DisclosureSEC source: 0001225208-25-002922 · doc4.xml · nonDerivative · entry 3 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 177,204 F4 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC |
Cordani DavidDirector · Chairman & CEO
|
GrantCommon Stock, $.01 Par Value | 11,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002922 · doc4.xml · nonDerivative · entry 2 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 181,900 F3 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.